Zdrowie i gospodarka · 18/06/2001
FDA Amends Animal Drug Regulations to Reflect Change in Sponsor
The FDA is updating its regulations to reflect the change in sponsor for three approved new animal drug applications for oxytetracycline premixes from Pfizer to Phibro Animal Health, Inc.
Source: Federal Register — Food and Drug AdministrationOpen original release →